Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


01.01.2017

1 AIDS
1 Am J Med
3 Clin Infect Dis
1 Gastroenterol Hepatol
6 Hepatology
2 J Hepatol
3 J Infect Dis
1 J Med Virol
3 J Viral Hepat
4 Lancet Infect Dis
1 N Engl J Med
3 Pediatr Infect Dis J
4 PLoS One
2 Transplantation
3 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. PETERS L, Cozzi-Lepri A
    Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Positive Patients?
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001378.
    PubMed     Text format     Abstract available


    Am J Med

  2. BESTE LA, Glorioso TJ, Ho PM, Au DH, et al
    Telemedicine specialty support promotes hepatitis c treatment by primary care providers in the Department of Veterans Affairs.
    Am J Med. 2016 Dec 17. pii: S0002-9343(16)31227.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  3. LIEVELD FI, Arends JE, Amelung L, Dijk E, et al
    Overcoming Outpatient Loss to Follow-up as a Barrier to Efficiently Instituting Hepatitis B Liver-related Care.
    Clin Infect Dis. 2016.
    PubMed     Text format    

  4. FOSTER AL, Gaisa MM, Hijdra RM, Turner SS, et al
    Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men.
    Clin Infect Dis. 2016 Nov 9. pii: ciw740. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. MASSIMO A, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2016 Dec 22. pii: ciw846. doi: 10.1093.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  6. GUARDIOLA AREVALO A, Gomez Rodriguez R, Romero Gutierrez M, Gomez Moreno AZ, et al
    Characteristics and course of chronic hepatitis B e antigen-negative infection.
    Gastroenterol Hepatol. 2016 Dec 19. pii: S0210-5705(16)30163.
    PubMed     Text format     Abstract available


    Hepatology

  7. LANTON T, Shriki A, Nechemia-Arbely Y, Abramovitch R, et al
    IL6-Dependent Genomic Instability Heralds Accelerated Carcinogenesis Following Liver Regeneration on a Background of Chronic Hepatitis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29004.
    PubMed     Text format     Abstract available

  8. KOWDLEY KV, Sundaram V, Jeon CY, Qureshi K, et al
    Eight weeks of Ledipasvir/Sofosbuvir is effective for selected patients with genotype 1 Hepatitis C virus infection.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29005.
    PubMed     Text format     Abstract available

  9. BALISTRERI WF, Murray KF, Rosenthal P, Bansal S, et al
    The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12 to 17 Years Old With Hepatitis C Virus Genotype 1 Infection.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28995.
    PubMed     Text format     Abstract available

  10. SUN Y, Zhou J, Wang L, Wu X, et al
    New Classification of Liver Biopsy Assessment for Fibrosis in Chronic Hepatitis B Patients Before and After Treatment.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29009.
    PubMed     Text format     Abstract available

  11. SETO WK, Sau-Yan Chan T, Hwang YY, Wong DK, et al
    Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29022.
    PubMed     Text format     Abstract available

  12. VIETHEER P, Boo I, Gu J, McCaffrey K, et al
    The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28989.
    PubMed     Text format     Abstract available


    J Hepatol

  13. VUKOTIC R, Conti F, Andreone P
    Hepatitis C virus eradication in elderly: The challenge worth a long-life elixir?
    J Hepatol. 2016 Dec 21. pii: S0168-8278(16)30745.
    PubMed     Text format    

  14. YAMAMOTO N, Sato Y, Munakata T, Kakuni M, et al
    Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection.
    J Hepatol. 2016;64:547-55.
    PubMed     Text format     Abstract available


    J Infect Dis

  15. MANOR Y, Lewis M, Ram D, Daudi N, et al
    Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groups.
    J Infect Dis. 2016 Dec 23. pii: jiw611. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. CHENG A, Chang SY, Sun HY, Tsai MS, et al
    Long-term durability of responses to 2 or 3 doses of hepatitis A vaccination in HIV-positive adults on antiretroviral therapy.
    J Infect Dis. 2016 Dec 23. pii: jiw605. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. CHEN MH, Chen MH, Liu CY, Tsai CY, et al
    Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients undergoing Biologics Treatment.
    J Infect Dis. 2016 Dec 23. pii: jiw606. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  18. LIU X, Zhang L, Wu XP, Zhu XL, et al
    Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle.
    J Med Virol. 2016 Dec 22. doi: 10.1002/jmv.24756.
    PubMed     Text format     Abstract available


    J Viral Hepat

  19. MARTINELLO M, Grebely J, Petoumenos K, Gane E, et al
    HCV reinfection incidence among individuals treated for recent infection.
    J Viral Hepat. 2016 Dec 27. doi: 10.1111/jvh.12666.
    PubMed     Text format     Abstract available

  20. PAN CQ, Yi W, Liu M, Wan G, et al
    Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B.
    J Viral Hepat. 2016 Dec 26. doi: 10.1111/jvh.12640.
    PubMed     Text format     Abstract available

  21. THARINGER H, Rebbapragada I, Samuel D, Novikov N, et al
    Antibody-dependent and -independent uptake of HBsAg across human leukocyte subsets is similar between individuals with chronic hepatitis B Virus infection and healthy donors.
    J Viral Hepat. 2016 Dec 23. doi: 10.1111/jvh.12667.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  22. DETERDING K, Spinner CD, Schott E, Welzel TM, et al
    Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study.
    Lancet Infect Dis. 2016 Oct 28. pii: S1473-3099(16)30408.
    PubMed     Text format     Abstract available

  23. UJIIE M, Sasaki K, Yoshikawa N, Enami T, et al
    Introduction of a hepatitis B vaccine into the national routine immunisation programme of Japan.
    Lancet Infect Dis. 2016;16:1325.
    PubMed     Text format    

  24. COILLY A, Samuel D
    Cutting out the roots of acute hepatitis C.
    Lancet Infect Dis. 2016 Oct 28. pii: S1473-3099(16)30406.
    PubMed     Text format    

  25. GOUTZAMANIS S, Doyle J, Thompson A, Hellard M, et al
    Direct-acting antiviral treatment for HCV.
    Lancet Infect Dis. 2016;16:1325-1326.
    PubMed     Text format    


    N Engl J Med

  26. FRIEDMAN LS, Lee SR, Nelson SB, Masia R, et al
    Case 36-2016.
    N Engl J Med. 2016;375:2082-2092.
    PubMed     Text format    


    Pediatr Infect Dis J

  27. MAJEKODUNMI AO, Thorne C, Malyuta R, Volokha A, et al
    Hepatitis C Co-Infection and CD4+ T Cell Recovery in HIV-Infected Children Receiving Anti-Retroviral Therapy.
    Pediatr Infect Dis J. 2016 Dec 15. doi: 10.1097/INF.0000000000001478.
    PubMed     Text format     Abstract available

  28. AURPIBUL L, Lumbiganon P, Hansudewechakul R, Kanjanavanit S, et al
    Response to Tenofovir Among Lamivudine-Experienced Hepatitis B and HIV Coinfected Adolescents.
    Pediatr Infect Dis J. 2016 Dec 21. doi: 10.1097/INF.0000000000001491.
    PubMed     Text format     Abstract available

  29. KOLASA M, Tsai Y, Xu J, Fenlon N, et al
    Hepatitis B surface Antigen Testing Among Pregnant Women, United States 2014.
    Pediatr Infect Dis J. 2016 Dec 27. doi: 10.1097/INF.0000000000001516.
    PubMed     Text format     Abstract available


    PLoS One

  30. EL-GHITANY EM, Farghaly AG, Farag S, Abd El-Wahab EW, et al
    Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.
    PLoS One. 2016;11:e0168649.
    PubMed     Text format     Abstract available

  31. SARRAZIN C, Manns M, Calleja JL, Garcia-Samaniego J, et al
    HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment.
    PLoS One. 2016;11:e0168544.
    PubMed     Text format     Abstract available

  32. VILLANI R, Facciorusso A, Bellanti F, Tamborra R, et al
    DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.
    PLoS One. 2016;11:e0167934.
    PubMed     Text format     Abstract available

  33. CHUNG JW, Kim BH, Lee CS, Kim GH, et al
    Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.
    PLoS One. 2016;11:e0168189.
    PubMed     Text format     Abstract available


    Transplantation


  34. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation: Erratum.
    Transplantation. 2017;101:e40.
    PubMed     Text format    

  35. LUBETZKY M, Chun S, Joelson A, Coco M, et al
    Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients with Directly Acting Antiviral Agents.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001618.
    PubMed     Text format     Abstract available


    Vaccine

  36. KARVONEN T, Auranen K, Kuusi M, Leino T, et al
    Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy.
    Vaccine. 2017;35:412-418.
    PubMed     Text format     Abstract available

  37. KANG W, Li Q, Shen L, Zhang L, et al
    Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31223.
    PubMed     Text format     Abstract available

  38. KULKARNI SP, Thanapati S, Arankalle VA, Tripathy AS, et al
    Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.
    Vaccine. 2016;34:5895-5902.
    PubMed     Text format     Abstract available


    Virology

  39. WINER BY, Huang T, Low BE, Avery C, et al
    Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.
    Virology. 2016;502:63-72.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: